Compare CI & BTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CI | BTI |
|---|---|---|
| Founded | 1792 | 1902 |
| Country | United States | United Kingdom |
| Employees | N/A | 48989 |
| Industry | Medical Specialities | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.6B | 126.4B |
| IPO Year | N/A | N/A |
| Metric | CI | BTI |
|---|---|---|
| Price | $272.26 | $58.18 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 17 | 3 |
| Target Price | ★ $353.59 | $62.00 |
| AVG Volume (30 Days) | 1.5M | ★ 2.8M |
| Earning Date | 02-05-2026 | 02-15-2026 |
| Dividend Yield | 2.22% | ★ 5.25% |
| EPS Growth | ★ 114.09 | N/A |
| EPS | ★ 22.63 | 1.89 |
| Revenue | ★ $268,077,000,000.00 | $35,067,817,512.00 |
| Revenue This Year | $12.85 | $0.27 |
| Revenue Next Year | $4.62 | $3.18 |
| P/E Ratio | ★ $12.03 | $30.13 |
| Revenue Growth | ★ 15.26 | N/A |
| 52 Week Low | $239.51 | $35.37 |
| 52 Week High | $350.00 | $59.29 |
| Indicator | CI | BTI |
|---|---|---|
| Relative Strength Index (RSI) | 46.38 | 61.79 |
| Support Level | $268.95 | $53.28 |
| Resistance Level | $278.00 | $56.80 |
| Average True Range (ATR) | 6.62 | 0.79 |
| MACD | -0.72 | 0.26 |
| Stochastic Oscillator | 17.58 | 98.00 |
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.
The third-largest tobacco company by volume, British American Tobacco sold 518 billion cigarettes in 2024. Its leading brands are Dunhill, Kent, Pall Mall, Lucky Strike, and Rothmans in cigarettes. Its ownership of the Camel, Natural American Spirit, and Newport brands are limited to the US. In next-generation products, the company has the Vuse brand in vaping, Glo in heated tobacco, and Velo in modern oral tobacco. The company also owns a 22.9% stake in ITC limited, the largest Indian cigarette company.